Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| PRECIGEN, INC. | 3,768,872 | reported | 28 May 2026 | tx 114+24,527,218−7,635,919 |
| Kinnate Biopharma Inc. | 0 | reported | 03 Apr 2024 | tx 6+85,751−85,751 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 28 May 2026 | SALE | PRECIGEN, INC. | 119,250 | 4.36 USD | |
| 23 May 2026 | EXERCISE | PRECIGEN, INC. | 250,000 | — | |
| 23 May 2026 | EXERCISE | PRECIGEN, INC. | 250,000 | 0.00 USD | deriv |
| 20 Apr 2026 | GRANT_AWARD | PRECIGEN, INC. | 1,366,000 | 0.00 USD | deriv |
| 20 Apr 2026 | GRANT_AWARD | PRECIGEN, INC. | 410,000 | 0.00 USD | deriv |
| 18 Mar 2026 | EXERCISE | PRECIGEN, INC. | 321,100 | — | |
| 18 Mar 2026 | GRANT_AWARD | PRECIGEN, INC. | 321,100 | 0.00 USD | deriv |
| 18 Mar 2026 | EXERCISE | PRECIGEN, INC. | 321,100 | 0.00 USD | deriv |
| 12 Sept 2025 | GRANT_AWARD | PRECIGEN, INC. | 825,000 | 0.00 USD | deriv |
| 26 Jun 2025 | GRANT_AWARD | PRECIGEN, INC. | 500,000 | 0.00 USD | deriv |
| 23 May 2025 | GRANT_AWARD | PRECIGEN, INC. | 1,000,000 | 0.00 USD | deriv |
| 16 May 2025 | TAX_WITHHOLDING | PRECIGEN, INC. | 521,224 | 1.45 USD | |
| 16 May 2025 | EXERCISE | PRECIGEN, INC. | 1,079,137 | — | |
| 16 May 2025 | EXERCISE | PRECIGEN, INC. | 1,079,137 | 0.00 USD | deriv |
| 17 Apr 2025 | GRANT_AWARD | PRECIGEN, INC. | 1,079,137 | 0.00 USD | deriv |
| 29 Jan 2025 | GRANT_AWARD | PRECIGEN, INC. | 825,000 | 0.00 USD | |
| 29 Jan 2025 | TAX_WITHHOLDING | PRECIGEN, INC. | 286,967 | 1.30 USD | |
| 31 May 2024 | GRANT_AWARD | PRECIGEN, INC. | 1,803,000 | 0.00 USD | deriv |
| 05 Apr 2024 | EXERCISE | PRECIGEN, INC. | 1,071,429 | — | |
| 05 Apr 2024 | TAX_WITHHOLDING | PRECIGEN, INC. | 410,357 | 1.40 USD | |
| 05 Apr 2024 | GRANT_AWARD | PRECIGEN, INC. | 1,071,429 | 0.00 USD | deriv |
| 05 Apr 2024 | EXERCISE | PRECIGEN, INC. | 1,071,429 | 0.00 USD | deriv |
| 03 Apr 2024 | OTHER | Kinnate Biopharma Inc. | 25,000 | — | deriv |
| 03 Apr 2024 | OTHER | Kinnate Biopharma Inc. | 40,501 | — | deriv |
| 03 Apr 2024 | OTHER | Kinnate Biopharma Inc. | 20,250 | — | deriv |